EUSTIS, Fla., May 23 /PRNewswire/ -- Valensa International has
appointed Dr. Rudi E. Moerck as President. In his new role, Dr. Moerck will
lead both the technology development and new product commercialization
efforts for the company, which already offers innovative natural
botanical-sourced products such as ZANTHIN(R) astaxanthin, USPlus Saw
Palmetto, CRANBEROL(R) cranberry seed extract and more. In a career that
spans more than 25 years, Dr. Moerck has held senior management positions
in both the pharmaceutical and specialty chemical industries, as well as
having research and commercial development experience. He holds patents in
the areas of amino acid technology and nanotechnology and is the principal
inventor of RenaZorb(TM), a new drug candidate for serum phosphate control
in kidney dialysis patients with end stage renal disease.
"The nutraceutical and botanical products industries are an important
part of our culture and becoming increasingly more so -- as is evidenced by
the growth of sectors like functional foods and cosmeceuticals," he said.
"Ultimately, it will be our ability to deliver wellness to the consumer
that will define our success -- and this will require creativity,
scientific rigor, the right mix of technology and commercial acumen," he
Prior to joining Valensa, Dr. Moerck was President of Altair
Nanotechnologies. While at Altair, he was the principal inventor of
RenaZorb(TM). RenaZorb(TM) was licensed by Spectrum Pharmaceuticals of
Irvine, CA in January 2005. While at Altair, he was also the chief
innovator of a new drug delivery system called TiNano Spheres(TM) for
enhanced drug release or timed release for pharmaceuticals. His work in the
pharmaceutical industry includes postings at Catalytica Pharmaceuticals as
Sr. Vice President Sales and Marketing, V.P. and General Manager API
manufacturing and R&D and also as President of the Fine Chemicals and
Pharmaceuticals Group at Cambrex Corporation.
Earlier in his career, Dr. Moerck worked at Degussa AG, a global
chemicals and materials company where he held positions ranging from Senior
Scientist and Pharmaceutical Plant Manager to Vice President where he was
responsible for the development of Degussa's North American hydrogen
peroxide business and the development of technology/services packages
serving a wide range of industries.
Dr. Moerck was awarded his Ph.D. in Organic Chemistry from the
University of Florida and a Bachelor of Science degree in Biology from
Florida Southern College. He received postdoctoral fellowships from both
the National Science Foundation and the National Institutes of Health. Dr.
Moerck taught pre- medical organic chemistry at Ohio State University and
at Ohio Wesleyan University.
About Valensa International
Headquartered in Eustis, Florida, USA (near Orlando), Valensa
International is a leading science-based developer and manufacturer of
high- quality botanical sourced products for nutraceutical supplements,
functional foods, human nutrition and cosmeceuticals. The Valensa
organization is a leading supplier of two important ingredients --
ZANTHIN(R) astaxanthin and USPlus(R) saw palmetto extract. In addition, the
company markets a line of high value botanical extracts including
CRANBEROL(R) cranberry seed oil, ginger, rosemary, oregano, and Valerex(R)
valerian oils and oleoresins.
For further information contact:
Sid Hulse, Vice President, Marketing & Sales
Voice: 352-357-2004 ext. 743
This release was issued through eReleases(TM). For more information,
SOURCE Valensa International